Related Experiment Video
Updated: Sep 7, 2025

07:47
Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function
Published on: February 4, 2016
13.2K
Non-invasive brain stimulation and neuroenhancement
Andrea Antal1, Bruce Luber2, Anna-Katharine Brem3,4
1Department of Neurology, University Medical Center, Göttingen, Germany.
Clinical Neurophysiology Practice
|June 23, 2022
Summary
Low-intensity transcranial electrical stimulation (tES) and other brain stimulation methods show potential for enhancing cognition. However, efficacy varies, and safety depends on strict adherence to established protocols and device design, especially for consumer devices.
Area of Science:
- Neuroscience
- Cognitive Science
- Biomedical Engineering
Background:
- Growing global elderly population and predicted rise in age-associated cognitive decline necessitate research into cognitive enhancement.
- Transcranial brain stimulation techniques, including transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES), are explored for cognitive improvement.
Purpose of the Study:
- To review and compare the efficacy of low-intensity tES for cognitive enhancement against repetitive TMS and pharmacological agents like caffeine and nicotine.
- To highlight critical factors influencing the variability and reproducibility of tES outcomes, particularly for self-directed devices.
Main Methods:
- Systematic review and comparison of existing data on low-intensity tES, repetitive TMS, and pharmacological agents.
- Analysis of factors affecting non-invasive brain stimulation outcomes, including device parameters, operator skill, and participant characteristics.
- Examination of safety considerations and regulatory distinctions for consumer-grade brain stimulation devices.
Main Results:
- No brain stimulation method yields exclusively positive outcomes; variability in efficacy is a significant challenge, especially for self-directed tES.
- Reproducibility is contingent on equipment, operator expertise, and rigorous control of stimulation parameters (dose, timing, participant factors, placebo effects).
- Low-intensity tES is considered safe when adhering to established protocols and using devices with proper risk management; consumer devices require ethical marketing.
Conclusions:
- Optimizing self-directed tES efficacy requires device designs that account for human factors and minimize variability.
- Strict control over stimulation parameters and consideration of placebo/nocebo effects are crucial for reliable cognitive enhancement outcomes.
- Safety and efficacy claims for consumer brain stimulation devices must be supported by evidence from similar devices and protocols, adhering to ethical marketing practices.
Keywords:
AD, Alzheimer’s DiseaseBDNF, brain derived neurotrophic factorCognitive enhancementDARPA, Defense Advanced Research Projects AgencyDIY stimulationDIY, Do-It-YourselfDLPFC, dorsolateral prefrontal cortexEEG, electroencephalographyEMG, electromyographyFCC, Federal Communications CommissionFDA, (U.S.) Food and Drug AdministrationHome-stimulationIFCN, International Federation of Clinical NeurophysiologyLTD, long-term depressionLTP, long-term potentiationMCI, mild cognitive impairmentMDD, Medical Device DirectiveMDR, Medical Device RegulationMEP, motor evoked potentialMRI, magnetic resonance imagingNIBS, noninvasive brain stimulationNeuroenhancementOTC, Over-The-CounterPAS, paired associative stimulationPET, positron emission tomographyPPC, posterior parietal cortexQPS, quadripulse stimulationRMT, resting motor thresholdSAE, serious adverse eventSMA, supplementary motor cortexTBS, theta-burst stimulationTMS, transcranial magnetic stimulationTranscranial brain stimulationrTMS, repetitive transcranial magnetic stimulationtACStACS, transcranial alternating current stimulationtDCStDCS, transcranial direct current stimulationtES, transcranial electric stimulationtRNS, transcranial random noise stimulationRelated Concept Videos
Brain Imaging
306
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
306
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206

